Mesalamine Capsule, Delayed Release
Product Images NDC 0093-5907

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 0093-5907). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

1 (Image 1)

1 (Image 1)
This text is not available for evaluation as it is very short and does not convey any meaning or context for generating a useful description.*
FDA Label Image

1 (Image 2)

1 (Image 2)
This text is the description and instructions for use of a medication in capsule form containing 100mg of mesatamine. The medication is to be stored between 20-25°C and dispensed in a light-resistant container with a closure. It can be taken with or without food. The text also includes the manufacturer's information and trademark disclaimer. The product is serialized with the GTIN 0030935907864 and the NDC 0093-5907-86.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.